Pharma

Your Article Summary

See Latest Articles

Buy Eli Lilly
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/23/08

Cramer’s latest pick from the sector is Eli Lilly , which is offering a healthy 5.2% dividend yield right now. The company just upped that payout for the 42nd year in a row, so investors can feel pretty confidant the dividend’s safe. And since big money managers live by the aforementioned thesis – biotech in a recession – their moves into the stock should push the share price higher.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09

 See all of Biotechnology